Literature DB >> 9972793

DNA-PK-independent rejoining of DNA double-strand breaks in human cell extracts in vitro.

N Cheong1, A R Perrault, H Wang, P Wachsberger, P Mammen, I Jackson, G Iliakis.   

Abstract

PURPOSE: To investigate the role of DNA-dependent protein kinase (DNA-PK) in the rejoining of ionizing radiation-induced DNA double-strand breaks (dsb).
MATERIALS AND METHODS: This study employed previously described in vitro assays that utilize nuclei or 'naked' DNA prepared from agarose-embedded cells as a substrate and S-HeLa cell extracts as a source of enzymes. Rejoining of dsb in these assays is absolutely dependent on cell extract and it proceeds, under optimal reaction conditions, to an extent similar to that observed in intact cells. Results were confirmed in a plasmid-based assay for in vitro rejoining of dsb.
RESULTS: It is shown that concentrations of wortmannin completely inhibiting DNA-PK activity profoundly affect the rejoining of dsb in vivo, but have no effect on dsb rejoining in vitro. Furthermore, fractionation of cell extracts using ammonium sulphate precipitation, generates protein fractions that are able to support dsb rejoining, despite the fact that they do not contain detectable amounts of either DNA-PKcs or Ku80. Efficient rejoining of dsb in vitro is also observed with extracts of MO59J cells that lack DNA-PK activity. Finally, rejoining of dsb remains unaffected by wortmannin in a plasmid-based assay, and is also detectable with extracts of MO59J cells.
CONCLUSIONS: These findings are in contrast with genetic studies demonstrating a requirement for DNA-PK activity for efficient rejoining of dsb in vivo. The difference between in vitro and in vivo results may not be attributed to chromatin structure since wortmannin was without an effect when using nuclei as a substrate. It is speculated that the differences between in vivo and in vitro results can be explained either by assuming the operation of multiple pathways in dsb rejoining, some of which do not require DNA-PK, or by postulating a purely regulatory/damage-sensing role for DNA-PK in intact cells but no direct involvement in dsb rejoining.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9972793     DOI: 10.1080/095530099140825

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  6 in total

1.  Merotelic attachments and non-homologous end joining are the basis of chromosomal instability.

Authors:  Astrid Alonso Guerrero; Carlos Martínez-A; Karel Hm van Wely
Journal:  Cell Div       Date:  2010-05-17       Impact factor: 5.130

2.  The Mre11/Rad50/Nbs1 complex functions in resection-based DNA end joining in Xenopus laevis.

Authors:  Elaine M Taylor; Sophie M Cecillon; Antonio Bonis; J Ross Chapman; Lawrence F Povirk; Howard D Lindsay
Journal:  Nucleic Acids Res       Date:  2009-11-05       Impact factor: 16.971

3.  Binding of the DNA-dependent protein kinase catalytic subunit to Holliday junctions.

Authors:  Ramiro Dip; Hanspeter Naegeli
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

4.  Coincident In Vitro Analysis of DNA-PK-Dependent and -Independent Nonhomologous End Joining.

Authors:  Cynthia L Hendrickson; Shubhadeep Purkayastha; Elzbieta Pastwa; Ronald D Neumann; Thomas A Winters
Journal:  J Nucleic Acids       Date:  2010-07-25

5.  Effects of camptothecin on double-strand break repair by non-homologous end-joining in DNA mismatch repair-deficient human colorectal cancer cell lines.

Authors:  Sandrine Jacob; Catherine Miquel; Alain Sarasin; Françoise Praz
Journal:  Nucleic Acids Res       Date:  2005-01-07       Impact factor: 16.971

6.  Opposite effects of the triple target (DNA-PK/PI3K/mTOR) inhibitor PI-103 on the radiation sensitivity of glioblastoma cell lines proficient and deficient in DNA-PKcs.

Authors:  Vladimir L Sukhorukov; Michael Flentje; Cholpon S Djuzenova; Thomas Fischer; Astrid Katzer; Dmitri Sisario; Tessa Korsa; Gudrun Steussloff
Journal:  BMC Cancer       Date:  2021-11-11       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.